These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38816274)

  • 1. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
    Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
    Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
    Chung SR; Baek JH; Choi YJ; Lee JH
    Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
    Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma.
    Monchik JM; Donatini G; Iannuccilli J; Dupuy DE
    Ann Surg; 2006 Aug; 244(2):296-304. PubMed ID: 16858194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
    Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
    Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
    Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
    Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-Year Outcomes of Radiofrequency Ablation for Locally Recurrent Papillary Thyroid Cancer.
    Chung SR; Baek JH; Choi YJ; Lee JH
    Korean J Radiol; 2024 Sep; 25(9):851-858. PubMed ID: 39197830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
    Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status.
    Chen WC; Chou CK; Chang YH; Chiang PL; Lim LS; Chi SY; Luo SD; Lin WC
    Front Endocrinol (Lausanne); 2022; 13():933931. PubMed ID: 35992153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.
    Lim HK; Baek JH; Lee JH; Kim WB; Kim TY; Shong YK; Hong SJ
    Eur Radiol; 2015 Jan; 25(1):163-70. PubMed ID: 25199815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review.
    Yoo RE; Kim JH; Paeng JC; Park YJ
    Medicine (Baltimore); 2018 Mar; 97(9):e0003. PubMed ID: 29489641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
    Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation.
    Baumann BC; Baumann JC; Christodouleas JP; Soffen E
    Brachytherapy; 2017; 16(2):291-298. PubMed ID: 28139422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
    Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
    Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
    Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma.
    Lee SJ; Jung SL; Kim BS; Ahn KJ; Choi HS; Lim DJ; Kim MH; Bae JS; Kim MS; Jung CK; Chong SM
    Korean J Radiol; 2014; 15(6):817-26. PubMed ID: 25469095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Efficacy of Radiofrequency Ablation for Recurrent Tumor at the Central Compartment After Hemithyroidectomy.
    Chung SR; Baek JH; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
    AJR Am J Roentgenol; 2021 Jun; 216(6):1574-1578. PubMed ID: 33787293
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
    Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
    Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study.
    Choi Y; Jung SL; Bae JS; Lee SH; Jung CK; Jang J; Shin NY; Choi HS; Ahn KJ; Kim BS
    Int J Hyperthermia; 2019; 36(1):359-367. PubMed ID: 30836037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.